KPC Pharmaceuticals Inc Strategic Asset Allocation Index
KPC Pharmaceuticals Inc strategic asset allocation index. KPC Pharmaceuticals Inc (600422) has a Strategic Asset Allocation Index of 24.3% as of June 2023. Strategic assets (PP&E of CN¥1.27 Billion plus long-term investments of CN¥-) total CN¥1.27 Billion, measured against net assets of CN¥5.25 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See KPC Pharmaceuticals Inc (600422) balance sheet quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of KPC Pharmaceuticals Inc (2000–2021)
Strategic asset allocation index of KPC Pharmaceuticals Inc from 2000 to 2021. This chart shows how KPC Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 22 annual periods from 2000 to 2021. As of June 2023, the index stands at 24.3%, representing strategic assets of CN¥1.27 Billion against net assets of CN¥5.25 Billion CNY. Check tangible equity quality of KPC Pharmaceuticals Inc to evaluate the tangible quality of the company's equity base.
KPC Pharmaceuticals Inc Strategic Asset Allocation Index by Year (2000–2021)
KPC Pharmaceuticals Inc strategic asset allocation index by year from 2000 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for KPC Pharmaceuticals Inc from 2000 to 2021, covering 22 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see KPC Pharmaceuticals Inc market capitalisation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 27.5% | CN¥1.36 Billion | CN¥1.36 Billion | CN¥- | CN¥4.94 Billion | ▼ -3.5 pp |
| 2020 | 31.0% | CN¥1.43 Billion | CN¥1.43 Billion | CN¥- | CN¥4.60 Billion | ▼ -0.2 pp |
| 2019 | 31.2% | CN¥1.35 Billion | CN¥1.35 Billion | CN¥- | CN¥4.33 Billion | ▼ -14.3 pp |
| 2018 | 45.5% | CN¥1.80 Billion | CN¥1.22 Billion | CN¥573.90 Million | CN¥3.95 Billion | ▲ +6.9 pp |
| 2017 | 38.6% | CN¥1.45 Billion | CN¥987.30 Million | CN¥467.70 Million | CN¥3.77 Billion | ▲ +0.7 pp |
| 2016 | 37.9% | CN¥1.37 Billion | CN¥815.18 Million | CN¥552.44 Million | CN¥3.61 Billion | ▼ -2.4 pp |
| 2015 | 40.3% | CN¥1.34 Billion | CN¥762.37 Million | CN¥582.15 Million | CN¥3.34 Billion | ▲ +16.6 pp |
| 2014 | 23.7% | CN¥486.70 Million | CN¥486.70 Million | CN¥- | CN¥2.05 Billion | ▼ -10.6 pp |
| 2013 | 34.4% | CN¥645.81 Million | CN¥645.81 Million | CN¥- | CN¥1.88 Billion | ▼ -9.2 pp |
| 2012 | 43.6% | CN¥460.70 Million | CN¥460.70 Million | CN¥- | CN¥1.06 Billion | ▲ +7.6 pp |
| 2011 | 36.0% | CN¥330.03 Million | CN¥330.03 Million | CN¥- | CN¥917.52 Million | ▼ -0.5 pp |
| 2010 | 36.4% | CN¥298.88 Million | CN¥298.88 Million | CN¥- | CN¥820.15 Million | ▼ -5.3 pp |
| 2009 | 41.7% | CN¥307.92 Million | CN¥307.92 Million | CN¥- | CN¥738.35 Million | ▼ -7.1 pp |
| 2008 | 48.9% | CN¥327.54 Million | CN¥327.54 Million | CN¥- | CN¥670.50 Million | ▼ -6.3 pp |
| 2007 | 55.1% | CN¥350.05 Million | CN¥350.05 Million | CN¥- | CN¥635.17 Million | ▲ +6.6 pp |
| 2006 | 48.6% | CN¥283.51 Million | CN¥283.51 Million | CN¥- | CN¥583.86 Million | ▲ +0.7 pp |
| 2005 | 47.9% | CN¥281.69 Million | CN¥281.69 Million | CN¥- | CN¥588.02 Million | ▲ +16.1 pp |
| 2004 | 31.8% | CN¥229.66 Million | CN¥229.66 Million | CN¥- | CN¥723.20 Million | ▼ -1.4 pp |
| 2003 | 33.1% | CN¥218.53 Million | CN¥218.53 Million | CN¥- | CN¥659.95 Million | ▲ +6.8 pp |
| 2002 | 26.3% | CN¥150.32 Million | CN¥150.32 Million | CN¥- | CN¥571.17 Million | ▲ +1.6 pp |
| 2001 | 24.7% | CN¥138.10 Million | CN¥138.10 Million | CN¥- | CN¥559.74 Million | ▲ +2.5 pp |
| 2000 | 22.2% | CN¥123.69 Million | CN¥123.69 Million | CN¥- | CN¥557.64 Million | — |